Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Trends in Outpatient Chemotherapy for Thoracic Oncology].
Fukuda M, Yamaguchi H, Takemoto S, Senju H, Gyotoku H, Dotsu Y, Umeyama Y, Tsuchiya A, Ikeda T, Nose S, Honda T, Kobayashi K, Ishii K, Mukae H, Ashizawa K. Fukuda M, et al. Among authors: dotsu y. Gan To Kagaku Ryoho. 2020 Oct;47(10):1461-1464. Gan To Kagaku Ryoho. 2020. PMID: 33130741 Japanese.
Pulmonary Artery Sarcoma Overexpressing Platelet-derived Growth Factor Receptor α.
Takemoto S, Soda H, Iwasaki K, Kitazaki T, Sumiyoshi M, Harada T, Dotsu Y, Ogawara D, Fukahori S, Fukuda Y, Mukae H. Takemoto S, et al. Among authors: dotsu y. Intern Med. 2017;56(7):823-826. doi: 10.2169/internalmedicine.56.7731. Epub 2017 Apr 1. Intern Med. 2017. PMID: 28381750 Free PMC article.
Phase II study of nedaplatin and amrubicin as first-line treatment for advanced squamous cell lung cancer.
Taniguchi H, Yamaguchi H, Dotsu Y, Shimada M, Gyotoku H, Senju H, Takemoto S, Kitazaki T, Fukuda M, Ogawara D, Soda H, Nakatomi K, Sugasaki N, Kinoshita A, Nagashima S, Ikeda T, Nakamura Y, Sakamoto N, Obase Y, Fukuda M, Mukae H. Taniguchi H, et al. Among authors: dotsu y. Thorac Cancer. 2019 Sep;10(9):1764-1769. doi: 10.1111/1759-7714.13134. Epub 2019 Jul 16. Thorac Cancer. 2019. PMID: 31309738 Free PMC article. Clinical Trial.
Dose escalation study of amrubicin and cisplatin with concurrent thoracic radiotherapy for limited-disease small cell lung cancer.
Shimada M, Yamaguchi H, Fukuda M, Tomono H, Honda N, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Takemoto S, Ikeda T, Nakatomi K, Nakamura Y, Nagashima S, Yamazaki T, Mukae H. Shimada M, et al. Among authors: dotsu y. Cancer Chemother Pharmacol. 2019 Nov;84(5):1059-1064. doi: 10.1007/s00280-019-03940-0. Epub 2019 Sep 5. Cancer Chemother Pharmacol. 2019. PMID: 31486872 Clinical Trial.
Phase II study of ramucirumab and docetaxel for previously treated non-small cell lung cancer patients with malignant pleural effusion: Protocol of PLEURAM study.
Takemoto S, Fukuda M, Yamaguchi H, Ikeda T, Akagi K, Tomono H, Umeyama Y, Dotsu Y, Taniguchi H, Gyotoku H, Senju H, Kitazaki T, Nakatomi K, Nagashima S, Fukuda M, Kinoshita A, Soda H, Mukae H. Takemoto S, et al. Among authors: dotsu y. Thorac Cancer. 2020 Feb;11(2):389-393. doi: 10.1111/1759-7714.13279. Epub 2019 Dec 18. Thorac Cancer. 2020. PMID: 31851428 Free PMC article.
Amrubicin in previously treated patients with malignant pleural mesothelioma: A phase II study.
Ikeda T, Takemoto S, Senju H, Gyotoku H, Taniguchi H, Shimada M, Dotsu Y, Umeyama Y, Tomono H, Kitazaki T, Fukuda M, Soda H, Yamaguchi H, Fukuda M, Mukae H. Ikeda T, et al. Among authors: dotsu y. Thorac Cancer. 2020 Jul;11(7):1972-1978. doi: 10.1111/1759-7714.13490. Epub 2020 May 28. Thorac Cancer. 2020. PMID: 32462731 Free PMC article. Clinical Trial.
Remarkable response to pembrolizumab with platinum-doublet in PD-L1-low pulmonary sarcomatoid carcinoma: A case report.
Taniguchi H, Takemoto S, Ozasa M, Honda N, Suyama T, Umeyama Y, Dotsu Y, Nakao T, Tomohito K, Gyotoku H, Yamaguchi H, Miyazaki T, Sakamoto N, Obase Y, Fukuda M, Fukuoka J, Mukae H. Taniguchi H, et al. Among authors: dotsu y. Thorac Cancer. 2021 Apr;12(7):1126-1130. doi: 10.1111/1759-7714.13890. Epub 2021 Feb 19. Thorac Cancer. 2021. PMID: 33605089 Free PMC article.
39 results